Cadence Pharmaceuticals, Inc. (NASDAQ:CADX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.

Recs

0
Player Avatar pchop123 (76.56) Submitted: 7/10/2012 10:54:55 AM : Underperform Start Price: $4.02 CADX Score: -7.01

any upside to be realized may not be in the near future as sales can not be taken for granted

Featured Broker Partners


Advertisement